SUSAC'S SYNDROME (RETINOCOCHLEOCEREBRAL VASCULOPATHY)
https://doi.org/10.14412/1995-4484-2018-249-252
Abstract
Susac's syndrome (SS), or retinocochleocerebral vasculopathy, is an extremely rare severe incapacitating disease, the basis for which is assumed to be autoimmune disorders. SS is characterized by microangiopathy with a triad of lesions of the brain, inner ear, and retina and refers to interdisciplinary problems. The results of brain magnetic resonance imaging, retinal fluorescein angiography, and audiometry and the interaction of physicians of various specialties, such as rheumatologists, neurologists, ophthalmologists, and otolaryngologists, are of key importance for the diagnosis of SS. The paper describes a case of SS and reviews the literature with emphasis on pilot recommendations for the treatment of this condition, which have been published in 2018, suggesting the combined use of high-dose glucocorticoids, intravenous immunoglobulin, cytostatic agents, and rituximab.
About the Authors
T. V. Beketova
V.A.Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
Tatiana Beketova.
34A, Kashirskoe Shosse, Moscow 115522
R. N. Konovalov
Research Center of Nevrology
Russian Federation
Russian Federation
80, Volokolamskoe Shosse, Moscow 125367
References
1. Susac JO, Hardman JM, Selhorst JB. Microangiopathy of the brain and retina. Neurology. 1979;29(3):313-6. doi: 10.1212/WNL.29.3.313
2. Jarius S, Kleffner I, Dorr JM, et al. Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study. J Neuroinflamm. 2014;11:46. doi: 10.1186/1742-2094-11-46
3. Nazari F, Azimi A, Abdi S. What is Susac syndrome? – A brief review of articles. Iran J Neurol. 2014;13(4):209-14.
4. Shmidt TE. Rare demyelinating diseases of the central nervous system. Nevrologicheskii Zhurnal. 2016;(5):6-18 (In Russ.).
5. Van der Knaap MS, Valk J. MR of adrenoleukodystrophy: histopathologic correlations. AJNR Am J Neuroradiol. 1989;10 Suppl. 5:S12-4.
6. Dorr J, Krautwald S, Wildemann B, et al. Characteristics of Susac syndrome: a review of all reported cases. Nat Rev Neurol. 2013;9:307-16. doi: 10.1038/nrneurol.2013.82
7. Van der Kooij SM, van Buchem MA, Overbeek OM, et al. Susac syndrome: a report of four cases and a review of the literature. Neth J Med. 2015;73:10-6.
8. Vishnevskia-Dai V, Chapman J, Sheinfeld R, et al. Susac syndrome: clinical characteristics, clinical classification, and long-term prognosis. Medicine (Baltimore). 2016;95(43):5223. doi: 10.1097/MD.0000000000005223
9. Smith PE, Chitty CN, Williams G, Stephens D. Goya's deafness. Pract Neurol. 2008;8(6):370-7. doi: 10.1136/jnnp.2008.161349
10. Rennebohm RM, Asdaghi N, Srivastava S, Gertner E. Guidelines for treatment of Susac syndrome – An update. Int J Stroke. 2018 Jan 1:1747493017751737. doi: 10.1177/1747493017751737
11. Beketova TV. Granulomatosis with polyangiitis, which is pathogenetically associated with antineu trophil cytoplasmic antibodies: Clinical features. NauchnoPrakticheskaya Revmatologiya = Rheumatology Science and Practice. 2012;50(6):19-28 (In Russ.). doi: 10.14412/1995-4484-2012-1288
12. Beketova TV. Cogan's syndrome is a new nosological entity in the current classification of systemic vasculitis: A clinical case and a review of literature. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2016;54(4):463-8 (In Russ.). doi: 10.14412/1995-4484-2016-463-468
13. Sinnecker T, Kuchling J, Dusek P, et al. Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management. EPMA J. 2015;6(1):16. doi: 10.1186/s13167-015-0038-y
14. Kleffner I, Dorr J, Ringelstein M, et al. Diagnostic criteria for Susac syndrome. J Neurol Neurosurg Psychiatry. 2016;87:1287-95. doi: 10.1136/jnnp-2016-314295
15. Huale H, Donlon SL, Okuda DT. A case of Susac syndrome with cervical spinal cord involvement on MRI. J Neurol Sci. 2014;337(12):228-31. doi: 10.1016/j.jns.2013.11.040
16. Bernard JT, Romero R, Agrawal K, et al. Optical coherence tomography in Susac's syndrome. Mult Scler Relat Disord. 2014;3(1):110-6. doi: 10.1016/j.msard.2013.05.005
17. Zhovtis Ryerson L, Kister I, Snuderl M, et al. Incomplete Susac syndrome exacerbated after natalizumab. Neurol Neuroimmunol Neuroinflamm. 2015;2(5):151. doi: 10.1212/NXI.0000000000000151
18. Algahtani H, Shirah B, Amin M, et al. Susac syndrome misdiagnosed as multiple sclerosis with exacerbation by interferon beta therapy. Neuroradiol J. 2017 Jan 1:1971400917712265. doi: 10.1177/1971400917712265
19. Mateen FJ, Zubkov AY, Muralidharan R, et al. Susac syndrome: clinical characteristics and treatment in 29 new cases. Eur J Neurol. 2012;19:800-11. doi: 10.1111/j.1468-1331.2011.03627.x
Review
For citations:
Beketova T.V., Konovalov R.N. SUSAC'S SYNDROME (RETINOCOCHLEOCEREBRAL VASCULOPATHY). Rheumatology Science and Practice. 2018;56(2):249-252. (In Russ.) https://doi.org/10.14412/1995-4484-2018-249-252
Views:
4456
Email this article 